Sana Biotechnology Inc.

NASDAQ: SANA · Real-Time Price · USD
3.33
-0.10 (-2.92%)
At close: Aug 15, 2025, 3:59 PM
3.37
1.05%
After-hours: Aug 15, 2025, 06:12 PM EDT

Sana Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
15.49M 30.86M 27.73M 17.91M
Gross Profit
-15.49M -30.86M -27.73M -17.91M
Operating Income
-272.72M -326.9M -272.56M -356.91M
Interest Income
10.47M 9.94M 3.76M 676K
Pretax Income
-266.76M -283.25M -269.48M -355.93M
Net Income
-266.76M -283.25M -269.48M -355.93M
Selling & General & Admin
64.04M 73.3M 71.56M 50.41M
Research & Development
217.56M 221.64M 201M 306.5M
Other Expenses
n/a n/a -674K 305K
Operating Expenses
281.6M 294.94M 272.56M 356.91M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
272.72M 325.81M 272.56M 356.91M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
230.89M 194.54M 188.34M 166.43M
Shares Outstanding (Diluted)
230.89M 194.54M 188.34M 166.43M
EPS (Basic)
-1.16 -1.46 -1.43 -2.14
EPS (Diluted)
-1.16 -1.46 -1.43 -2.14
EBITDA
-251.27M -252.39M -256.94M -345.84M
EBIT
-266.76M -283.25M -269.48M -355.93M
Depreciation & Amortization
15.49M 30.86M 15.63M 11.07M